Mirtazapine in recurrent brief depression

International Clinical Psychopharmacology

Volumn 13, Issue 1, 1998, Pages 39-40

  Stamenkovic, M ^a   Pezawas, L ^a   De Zwaan, M ^a   Aschauer, H N ^a   Kasper, S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antidepressant treatment; Major depression; Mirtazapine; Recurrent brief depression

Indexed keywords

MIRTAZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; SUICIDE ATTEMPT; SYMPTOM;

EID: 0031938250     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199801000-00006     Document Type: Article

References (6)

1. 1A-mediated serotonergic neurotransmission. Central Nervous System Drugs, 4 (suppl 1), 29-38.
2. Kasper S, Stamenkovic M and Fischer G (1995) Recurrent brief depression-diagnosis, epidemiology and potential pharmacological options. Central Nervous System Drugs, 4, 222-229.
3. th International Congress for Suicide Prevention and Crisis Intervention; 19th June 1979; Ottawa. 227-229.
4. Montgomery SA, Roy D and Montgomery D (1983) The prevention of recurrent suicidal acts. British Journal of Clinical Pharmacology 15, 183S-188S.
5. Montgomery SA, Montgomery D and Evans R (1993) Pharmacological differences between brief and major depressions. European Neuropsychopharmacology 3(suppl 3), 214-215.
6. Montgomery D, Roberts A, Green M, Bullock T, Baldwin D and Montgomery SA (1994) Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. European Archives of Psychiatry and Clinical Neuroscience 244, 211-215.